Inflammatory bowel disease: Epidemiology, pathology and risk factors for hypercoagulability

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 1

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jan 7, 2014; 20(1): 53-63
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.53

Table 1 Acquired prothrombotic factors in inflammatory bowel diseases

Dehydration

Glucocorticosteroids therapy

Prolonged immobilization

Central venous catheters

Surgical procedures

Oral contraceptives/hormonal replacement therapy

Smoking

Hyperhomocysteinemia

Citation: Owczarek D, Cibor D, Głowacki MK, Rodacki T, Mach T. Inflammatory bowel disease: Epidemiology, pathology and risk factors for hypercoagulability. World J Gastroenterol 2014; 20(1): 53-63
URL: https://www.wjgnet.com/1007-9327/full/v20/i1/53.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i1.53

Owczarek D, Cibor D, Głowacki MK, Rodacki T, Mach T. Inflammatory bowel disease: Epidemiology, pathology and risk factors for hypercoagulability. World J Gastroenterol 2014; 20(1): 53-63 [PMID: 24415858 DOI: 10.3748/wjg.v20.i1.53]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.